(KN) Knowles Cor - Overview
Sector: Technology | Industry: Electronic Components | Exchange: NYSE (USA) | Market Cap: 3.137m USD | Total Return: 120.8% in 12m
Avg Turnover: 30.9M
EPS Trend: 16.8%
Qual. Beats: 0
Rev. Trend: -22.2%
Qual. Beats: 0
Warnings
Altman Z'' -2.52 < 1.0 - financial distress zone
Tailwinds
Supp Ema20, Rs Leader, Tailwind, Confidence
Knowles Corporation (KN) is an Illinois-based manufacturer of advanced micro-acoustic microphones, speakers, and high-performance capacitors. The company operates through two primary segments: Precision Devices (PD) and Medtech & Specialty Audio (MSA), providing critical components for the defense, industrial, and medical technology sectors.
The business model relies on the custom design of radio frequency (RF) filters and balanced armature speakers, which are essential for high-precision hearing health devices and electric vehicle power systems. The electronic components sector is characterized by high barriers to entry due to the specialized engineering required for extreme miniaturization and reliability in harsh environments.
The company maintains a global distribution network, selling directly to original equipment manufacturers (OEMs) and through authorized contract manufacturers. Analyzing Knowles’ historical valuation trends on ValueRay can provide further context on its current market position. Founded in 1946, Knowles remains a key supplier for the electrification and communications infrastructure markets.
- Defense and industrial demand drives high-margin Precision Devices segment revenue
- Hearing health market recovery accelerates balanced armature speaker sales volume
- Electric vehicle adoption expands total addressable market for ceramic capacitor products
- Operational efficiency and manufacturing footprint consolidation improve consolidated EBITDA margins
- Defense spending cycles dictate long-term growth for radio frequency filter solutions
| Net Income: 55.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -2.17 > 1.0 |
| NWC/Revenue: 33.63% < 20% (prev 30.83%; Δ 2.80% < -1%) |
| CFO/TA 0.11 > 3% & CFO 112.0m > Net Income 55.9m |
| Net Debt (130.7m) to EBITDA (122.4m): 1.07 < 3 |
| Current Ratio: 3.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (87.7m) vs 12m ago -0.11% < -2% |
| Gross Margin: 41.91% > 18% (prev 0.40%; Δ 4.15k% > 0.5%) |
| Asset Turnover: 57.10% > 50% (prev 50.35%; Δ 6.75% > 0%) |
| Interest Coverage Ratio: 10.60 > 6 (EBITDA TTM 122.4m / Interest Expense TTM 8.10m) |
| A: 0.20 (Total Current Assets 297.4m - Total Current Liabilities 90.9m) / Total Assets 1.05b |
| B: -0.53 (Retained Earnings -559.7m / Total Assets 1.05b) |
| C: 0.08 (EBIT TTM 85.9m / Avg Total Assets 1.08b) |
| D: -2.49 (Book Value of Equity -680.4m / Total Liabilities 273.7m) |
| Altman-Z'' = -2.52 = D |
| DSRI: 0.92 (Receivables 109.2m/106.9m, Revenue 614.1m/552.4m) |
| GMI: 0.95 (GM 41.91% / 40.01%) |
| AQI: 1.01 (AQ_t 0.56 / AQ_t-1 0.56) |
| SGI: 1.11 (Revenue 614.1m / 552.4m) |
| TATA: -0.05 (NI 55.9m - CFO 112.0m) / TA 1.05b) |
| Beneish M = -3.10 (Cap -4..+1) = AA |
As of May 26, 2026, the stock is trading at USD 36.66 with a total of 722,400 shares traded.
Over the past week, the price has changed by +4.38%,
over one month by +17.58%,
over three months by +28.72% and
over the past year by +120.84%.
Knowles Cor has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy KN.
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 36.3 | -1.1% |
P/E Trailing = 51.6338
P/E Forward = 15.2439
P/S = 5.1077
P/B = 4.0203
P/EG = 0.43
Revenue TTM = 614.1m USD
EBIT TTM = 85.9m USD
EBITDA TTM = 122.4m USD
Long Term Debt = 131.0m USD (from longTermDebt, last quarter)
Short Term Debt = 4.60m USD (from shortTermDebt, last quarter)
Debt = 171.7m USD (from shortLongTermDebtTotal, last quarter) + Leases 20.5m
Net Debt = 130.7m USD (calculated: Debt 171.7m - CCE 41.0m)
Enterprise Value = 3.27b USD (3.14b + Debt 171.7m - CCE 41.0m)
Interest Coverage Ratio = 10.60 (Ebit TTM 85.9m / Interest Expense TTM 8.10m)
EV/FCF = 44.70x (Enterprise Value 3.27b / FCF TTM 73.1m)
FCF Yield = 2.24% (FCF TTM 73.1m / Enterprise Value 3.27b)
FCF Margin = 11.90% (FCF TTM 73.1m / Revenue TTM 614.1m)
Net Margin = 9.10% (Net Income TTM 55.9m / Revenue TTM 614.1m)
Gross Margin = 41.91% ((Revenue TTM 614.1m - Cost of Revenue TTM 356.7m) / Revenue TTM)
Gross Margin QoQ = 41.28% (prev 42.23%)
Tobins Q-Ratio = 3.10 (Enterprise Value 3.27b / Total Assets 1.05b)
Interest Expense / Debt = 4.72% (Interest Expense 8.10m / Debt 171.7m)
Taxrate = 20.47% (13.1m / 64.0m)
NOPAT = 68.3m (EBIT 85.9m * (1 - 20.47%))
Current Ratio = 3.27 (Total Current Assets 297.4m / Total Current Liabilities 90.9m)
Debt / Equity = 0.22 (Debt 171.7m / totalStockholderEquity, last quarter 780.2m)
Debt / EBITDA = 1.07 (Net Debt 130.7m / EBITDA 122.4m)
Debt / FCF = 1.79 (Net Debt 130.7m / FCF TTM 73.1m)
Total Stockholder Equity = 763.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.20% (Net Income 55.9m / Total Assets 1.05b)
RoE = 4.22% (Net Income TTM 55.9m / Total Stockholder Equity 1.32b)
RoCE = 5.91% (EBIT 85.9m / Capital Employed (Equity 1.32b + L.T.Debt 131.0m))
RoIC = 7.37% (NOPAT 68.3m / Invested Capital 926.6m)
WACC = 10.78% (E(3.14b)/V(3.31b) * Re(11.16%) + D(171.7m)/V(3.31b) * Rd(4.72%) * (1-Tc(0.20)))
Discount Rate = 11.16% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -71.91 | Cagr: -1.48%
[DCF] Terminal Value 64.61% ; FCFF base≈83.8m ; Y1≈73.5m ; Y5≈59.4m
[DCF] Fair Price = 6.45 (EV 682.5m - Net Debt 130.7m = Equity 551.8m / Shares 85.6m; r=10.78% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 16.77 | EPS CAGR: 1.57% | SUE: 0.59 | # QB: 0
Revenue Correlation: -22.15 | Revenue CAGR: -1.87% | SUE: 0.11 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.30 | Chg30d=+4.27% | Revisions=+33% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.34 | Chg30d=+0.00% | Revisions=+0% | Analysts=4
EPS current Year (2026-12-31): EPS=1.29 | Chg30d=+4.23% | Revisions=+50% | GrowthEPS=+16.4% | GrowthRev=+8.4%
EPS next Year (2027-12-31): EPS=1.56 | Chg30d=+4.06% | Revisions=+43% | GrowthEPS=+20.5% | GrowthRev=+6.8%
[Analyst] Revisions Ratio: +50%